Danshensu for Myocardial Ischemic Injury: Preclinical Evidence and Novel Methodology of Quality Assessment Tool

• 主要な著者: Xiao-yi Bao (著者), Qun Zheng (著者), Qiang Tong (著者), Peng-chong Zhu (著者), Zhuang Zhuang (著者), Guo-qing Zheng (著者), Yan Wang (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2018-12-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Background: Danshensu (DSS) possesses unique bioactivity on the cardiovascular system. However, there is a lack of systematical summary of DSS for acute myocardial ischemia injury and no quality assessment tool for the systematical review of cell experiments. Here, we aimed to assess the preclinical...